Adjuvant Chemotherapy Could Benefit Patients With Localised Colorectal Cancer (Quasar Trial)

Chemotherapy with fluorouracil and folinic acid could improve survival of patients with stage II colorectal cancer compared with observation alone, although the absolute improvements are small. These are the conclusions of an Article in this week’s edition of The Lancet.Colorectal cancer is the second most common malignant disease in developed countries, with 1 million new cases and 500 000 deaths worldwide every year. [click link for full article]

More: continued here

Filed under: Colorectal Cancer on December 20th, 2007